Three IPOs and two SPACs priced this week, while five IPOs and three SPACs submitted filings. Those filings included a potential multibillion dollar offering from neocloud Nscale (NSCL). But perhaps the week’s biggest headline was that ...read more
Electra Therapeutics, a Phase 2/3 biotech developing SIRP-targeted antibodies for immune diseases and cancer, raised $350 million by offering 23.3 million shares at $15, within the $14 to $16 range. The company originally filed to offer 21.6 million shares at...read more
Electra Therapeutics, a Phase 2/3 biotech developing SIRP-targeted antibodies for immune diseases and cancer, announced terms for its IPO on Monday. The South San Francisco, CA-based company plans to raise $325 million by offering 21.7 million shares at a...read more
Updated on Monday, 9/14/26 Four sizable IPOs are currently scheduled for the week ahead, featuring nuclear power, biotech, insurance, and banking. Nuclear plant equipment and services provider Holtec Nuclear (HNUC) plans to raise $825 million at a $9.4...read more
US IPO Weekly Recap: Data center developer Nscale files, while Holtec Nuclear postpones IPO
Three IPOs and two SPACs priced this week, while five IPOs and three SPACs submitted filings. Those filings included a potential multibillion dollar offering from neocloud Nscale (NSCL). But perhaps the week’s biggest headline was that ...read more
Antibody biotech Electra Therapeutics prices upsized IPO at $15 midpoint
Electra Therapeutics, a Phase 2/3 biotech developing SIRP-targeted antibodies for immune diseases and cancer, raised $350 million by offering 23.3 million shares at $15, within the $14 to $16 range. The company originally filed to offer 21.6 million shares at...read more
Antibody biotech Electra Therapeutics sets terms for $325 million IPO
Electra Therapeutics, a Phase 2/3 biotech developing SIRP-targeted antibodies for immune diseases and cancer, announced terms for its IPO on Monday. The South San Francisco, CA-based company plans to raise $325 million by offering 21.7 million shares at a...read more
US IPO Week Ahead: Holtec Nuclear headlines the fall IPO market's first full week
Updated on Monday, 9/14/26 Four sizable IPOs are currently scheduled for the week ahead, featuring nuclear power, biotech, insurance, and banking. Nuclear plant equipment and services provider Holtec Nuclear (HNUC) plans to raise $825 million at a $9.4...read more